The earnings call reveals a mixed performance for Sonova. While there is notable success in product launches and specific growth areas like cochlear implants, the company faces profitability challenges and market headwinds in key regions. The balanced highlights and lowlights suggest steady progress amidst external pressures.
Company Guidance
During the Sonova Holding AG conference call discussing the half-year results for fiscal year 2024-2025, the company confirmed its guidance for the full year on both the top and bottom lines. Despite challenging market conditions, Sonova achieved a 5.9% sales growth in local currencies, driven by a 7% increase in hearing instruments and a 12.5% growth in cochlear implants. Organic growth was 4.5%, with M&A contributing 1.4%. EBITDA was impacted, decreasing by 180 basis points, primarily due to product launch costs and lead generation expenses. The company's efforts to counteract these headwinds include cost-tightening measures, particularly in Audiological Care and G&A. Sonova reported a gross profit margin improvement to 71.9% and an adjusted EBITA of CHF 325 million, representing a 17.7% margin. The company observed a significant positive impact from the launch of Infinio and Sphere, with a 50% share of Sphere contributing to a favorable ASP uplift. While challenges persist, particularly in the European market, Sonova remains confident in achieving its financial targets, supported by strong product performance and strategic cost management.
Solid Sales Growth
Sonova reported a 5.9% increase in sales in local currencies, driven by share gains in hearing instruments and cochlear implants, with hearing instruments achieving a 7% growth despite late cycle ASP pressure.
Positive Product Launch Impact
The launch of the Infinio and Sphere platforms received positive customer feedback and is expected to continue driving strong momentum, contributing to a significant market share gain in the U.S.
Cochlear Implants Growth
Cochlear implants experienced a 12.5% growth, with system sales up by 18.2%, indicating strong performance and market penetration.
Sonova Holding AG (CH:SOON) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CH:SOON Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 09, 2025
CHF249.17
CHF257.62
+3.39%
Nov 19, 2024
CHF311.48
CHF295.26
-5.21%
May 14, 2024
CHF259.16
CHF276.68
+6.76%
Nov 21, 2023
CHF226.25
CHF238.44
+5.39%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Sonova Holding AG (CH:SOON) report earnings?
Sonova Holding AG (CH:SOON) is schdueled to report earning on Nov 14, 2025, Before Open (Confirmed).
What is Sonova Holding AG (CH:SOON) earnings time?
Sonova Holding AG (CH:SOON) earnings time is at Nov 14, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.